Interestingly, the moderate expression of CCN2/CTGF is sufficient to modulate the TGF-β and BMP signaling pathway, causing a POAG like pathogenesis in the transgenic animals (Figure 7). The gene discussed is CCN2; the disease is open-angle glaucoma.